The role of atrial dilatation in development of chronic atrial fibrillation

Projektinformationen

NEUBERGER, HANS-RUPR

ID Finanzhilfevereinbarung: QLG1-CT-2000-51236

Projekt abgeschlossen

Startdatum 1 Januar 2001

Enddatum 31 Dezember 2002

Finanziert unter

• Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Gesamtkosten € 140 600,00

EU-Beitrag € 140 600,00

Koordiniert durch

UNIVERSITY OF MAASTRICHT
Netherlands

Ziel

The project investigates whether chronic a trial dilatation plays a causal role in a trial fibrillation. It uses a new method in a well-established goat model and will help to develop effective therapeutic strategies against this important arrhythmia.

Wissenschaftliches Gebiet

• medical and health sciences › clinical medicine › cardiology › cardiovascular diseases › cardiac arrhythmia

Programm/Programme

• FP5-LIFE QUALITY - Specific Programme for research, technological development and demonstration on "Quality of life and management of living resources", 1998-2002

Thema/Themen

• 1.1.1.-7. - Chronic and degenerative diseases, cancer, diabetes, cardivascular diseases and rare diseases

Aufforderung zur Vorschlagseinreichung

Data not available

Finanzierungsplan

RGI - Research grants (individual fellowships)

Koordinator

UNIVERSITY OF MAASTRICHT

• EU-Beitrag: Keine Daten
• Adresse: Universiteitssingel 50 ; 6200 MB MAASTRICHT ; Niederlande
• Gesamtkosten: Keine Daten